Accession Number: | 0000914190-20-000196 |
Date: | 2020-05-28 |
Issuer: | BIO-TECHNE CORP (TECH) |
Original Submission Date: |
FURLOW BRENDA S.
614 MCKINLEY PLACE NE
MINNEAPOLIS, MN 55413
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-05-28 | M | 5,995 | a | $108.49 | 8,706 | direct | ||
COMMON STOCK | 2020-05-28 | M | 1,600 | a | $94.35 | 10,306 | direct | ||
COMMON STOCK | 2020-05-28 | S | 2,195 | d | $259.72 | 8,111 | direct | ||
COMMON STOCK | 2020-05-28 | S | 3,800 | d | $260.38 | 4,311 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTIONS (RIGHT TO BUY) | 94.35 | 2020-05-28 | deemed execution date | M | 1,600 (d) | 2021-08-12 | common stock 1,600 | $94.35 | 0 | direct | ||
STOCK OPTIONS (RIGHT TO BUY) | 108.49 | 2020-05-28 | deemed execution date | M | 5,995 (d) | 2022-08-07 | common stock 5,995 | $108.49 | 10,000 | direct | ||
STOCK OPTIONS (RIGHT TO BUY) | 106.59 | 2020-05-28 | deemed execution date | 0 ( ) | 2023-08-18 | common stock 10,857 | $106.59 | 10,857 | direct | |||
STOCK OPTIONS (RIGHT TO BUY) | 106.59 | 2020-05-28 | deemed execution date | 0 ( ) | 2023-08-18 | common stock 14,476 | $106.59 | 14,476 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-05-28 | deemed execution date | 0 ( ) | common stock 1,724 | $0.00 | 1,724 | direct | ||||
STOCK OPTIONS (RIGHT TO BUY) | 125.05 | 2020-05-28 | deemed execution date | 0 ( ) | 2024-08-09 | common stock 9,503 | $125.05 | 9,503 | direct | |||
STOCK OPTIONS (RIGHT TO BUY) | 125.05 | 2020-05-28 | deemed execution date | 0 ( ) | 2024-08-09 | common stock 12,670 | $125.05 | 12,670 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-05-28 | deemed execution date | 0 ( ) | common stock 1,374 | $0.00 | 1,374 | direct | ||||
STOCK OPTIONS (RIGHT TO BUY) | 177.32 | 2020-05-28 | deemed execution date | 0 ( ) | 2025-08-08 | common stock 7,339 | $177.32 | 7,339 | direct | |||
STOCK OPTIONS (RIGHT TO BUY) | 177.32 | 2020-05-28 | deemed execution date | 0 ( ) | 2025-08-08 | common stock 9,786 | $177.32 | 9,786 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-05-28 | deemed execution date | 0 ( ) | common stock 1,969 | $0.00 | 1,969 | direct | ||||
STOCK OPTIONS (RIGHT TO BUY) | 190.41 | 2020-05-28 | deemed execution date | 0 ( ) | 2026-08-07 | common stock 9,968 | $190.41 | 9,968 | direct | |||
STOCK OPTIONS (RIGHT TO BUY) | 190.41 | 2020-05-28 | deemed execution date | 0 ( ) | 2026-08-07 | common stock 13,290 | $190.41 | 13,290 | direct |
ID | footnote |
---|---|
f1 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $259.0500 to $260.0400, inclusive. the reporting person undertakes to provide bio-techne corporation, any security holder of bio-techne corporation, or the staff of the securities and exchange commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $260.0800 to $261.0400, inclusive. the reporting person undertakes to provide bio-techne corporation, any security holder of bio-techne corporation, or the staff of the securities and exchange commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
f3 | each restricted stock unit represents a contingent right to receive one share of bio-techne common stock. |
f4 | fully exercisable. |
f5 | options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022. |
f6 | options to purchase 3,167 shares vest on each of 8/9/2018 and 8/9/2019 and options to purchase 3,168 shares vest on each of 8/9/2020 and 8/9/2021. |
f7 | options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023. |
f8 | options to purchase 3,619 shares vest on each of 8/18/2017, 8/18/2018, 8/18/2019 and 8/18/2020. |
f9 | vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the administrator). |
f10 | vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the administrator). |
f11 | vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the administrator). |